RELATIONSHIP BETWEEN ANDROGEN RECEPTOR-BINDING ACTIVITY IN HUMAN-PROSTATE CANCER AND CLINICAL-RESPONSE TO ENDOCRINE THERAPY

被引：0
|
作者：
BENSON, RC
GORMAN, PA
OBRIEN, PC
HOLICKY, EL
VENEZIALE, CM
机构：
[1] MAYO CLIN & MAYO FDN, DEPT BIOCHEM & MOLEC BIOL, ROCHESTER, MN 55905 USA
[2] MAYO CLIN & MAYO FDN, MED RES STAT SECT, ROCHESTER, MN 55905 USA
来源：
CANCER | 1987年 / 59卷 / 09期
关键词：
D O I：
10.1002/1097-0142(19870501)59:9<1599::AID-CNCR2820590913>3.0.CO;2-V
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1599 / 1606
页数：8
相关论文
共 50 条
  • [21] A Targeted Bivalent Androgen Receptor Binding Compound for Prostate Cancer Therapy
    Chowdhury, Shafinaz
    Beitel, Lenore K.
    Lumbroso, Rose
    Purisima, Enrico O.
    Paliouras, Miltiadis
    Trifiro, Mark
    HORMONES & CANCER, 2019, 10 (01): : 24 - 35
  • [22] BENZODIAZEPINES - RELATIONSHIP BETWEEN PHARMACOLOGICAL ACTIVITY IN THE RAT AND INVIVO RECEPTOR-BINDING
    MENNINI, T
    COTECCHIA, S
    CACCIA, S
    GARATTINI, S
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1982, 16 (04) : 529 - 532
  • [23] ANDROGEN BINDING IN PROSTATIC-CARCINOMA BY HISTOCHEMISTRY - CORRELATION WITH BIOCHEMICAL ANDROGEN RECEPTOR ASSAY AND CLINICAL-RESPONSE TO HORMONAL THERAPIES
    PERTSCHUK, LP
    ROSENTHAL, HE
    MACCHIA, RJ
    GAETJENS, E
    EISENBERG, KB
    LABORATORY INVESTIGATION, 1981, 44 (01) : A52 - A52
  • [24] ANDROGEN RECEPTORS IN ENDOCRINE-THERAPY-RESISTANT HUMAN PROSTATE-CANCER
    VANDERKWAST, TH
    SCHALKEN, J
    DEWINTER, JAR
    VANVROONHOVEN, CCJ
    MULDER, E
    BOERSMA, W
    TRAPMAN, J
    INTERNATIONAL JOURNAL OF CANCER, 1991, 48 (02) : 189 - 193
  • [25] RELATIONSHIP BETWEEN HORMONAL STATUS AND CLINICAL-RESPONSE IN HUMAN FIBROCYSTIC DISEASE
    FRAIOLI, F
    LAVECCHIA, V
    VITA, F
    SANTORO, F
    ORZI, C
    MARCELLINO, LR
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1979, 11 (5-6): : R29 - R29
  • [26] THE RELATIONSHIP BETWEEN PSYCHOLOGICAL FACTORS AND PHYSICAL ACTIVITY IN THE TREATMENT OF PROSTATE CANCER WITH ANDROGEN DEPRIVATION THERAPY
    Chipperfield, K.
    Burney, S.
    Fletcher, J.
    Millar, J.
    Smith, R.
    Oh, T.
    Walsh, C.
    Frydenberg, M.
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2012, 19 : S167 - S167
  • [27] OVARIAN-CANCER - RELATIONSHIP BETWEEN INVITRO CHEMOSENSITIVITY AND CLINICAL-RESPONSE
    CARENZA, L
    VILLANI, C
    RULLI, G
    LABI, FL
    PORTA, RP
    GYNECOLOGIC ONCOLOGY, 1990, 36 (01) : 13 - 18
  • [28] Is androgen receptor activity in metastatic prostate cancer a good biomarker for bipolar androgen therapy?
    Peinetti, Nahuel
    Bilusic, Marijo
    Burnstein, Kerry L.
    JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (23):
  • [29] BETA-ADRENERGIC-RECEPTOR ACTIVITY AND CLINICAL-RESPONSE IN INTERMITTENT DOBUTAMINE THERAPY
    APPLEFELD, MM
    ELFAKAHANY, EE
    ROFFMAN, DS
    RAMKUMAR, V
    SUTTON, FJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 5 (02) : 515 - 515
  • [30] Targeting the DNA binding domain of the androgen receptor as a potential therapy for prostate cancer
    Dalal, Kush
    Li, Huifang
    Moniri, Mani R.
    Ban, Fuqiang
    Sharma, Aishwariya
    Cherkasov, Artem
    Rennie, Paul S.
    CANCER RESEARCH, 2014, 74 (19)
12345